Search Results

Site Search

Driving change in women's health testing through pioneering research and novel testing strategies - Insights

New diagnostic tests specifically for conditions that predominantly or only affect women, such as autoimmune diseases and gynecological cancers, are empowering female patients and their physicians to make informed decisions.

Pathways Case Studies: August 2023 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for August include the following sub-specialties: Bone and Soft Tissue Pathology,...

Equity and Inclusion in Health Care: The Stakes Are Higher Than Ever - Insights

In this sketchnote, Sharonne Hayes, M.D., discusses the drivers behind equity and inclusion in health care and why we must act.

Mayo Clinic Laboratory and pathology research roundup: December 21 - Insights

This week’s research roundup features: Learning through a Pandemic: The current state of knowledge on COVID-19 and cancer.

Bleeding disorders - Insights

See how our Special Coagulation Laboratory offers algorithmic approaches to meet your bleeding disorder testing needs.

inflammatory-bowel-disease-diagnostic-testing-algorithm.pdf

YES <50 mcg/g <50 mcg/g Abnormal >50 mcg/g Normal ANCA present ASCA IgG and IgA absent ANCA absent ASCA IgG or IgA present ANCA absent ASCA IgG or IgA absent >120 mcg/g50-120 mcg/g NO Assessing a patient with diarrhea when differential...

Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 15 - Insights

This week’s Research Roundup highlights how the loss of FOXO1 cooperates with TMPRSS2-ERG overexpression to promote prostate tumorigenesis and cell invasion.

October 2023 - Coagulation - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Coagulation.

CNS Demyelinating Disease Testing - Mayo Clinic Laboratories

We offer the only FACS assay for CNS Demyelinating Disease. Our testing ensures the highest senstivity and specificity, providing the most accurate results for patients.

Jeff Meeusen, Ph.D., Provides Clinical Update on Ceramides - Insights

Jeff Meeusen, Ph.D., Co-Director of Cardiovascular Laboratory Medicine in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, provides a clinical update on ceramides.